MOXARIN Capsule, hard Ref.[28280] Active ingredients: Amoxicillin

Source: Υπουργείο Υγείας (CY)  Revision Year: 2021  Publisher: Codal-Synto Ltd, 21 Constantinoupoleos Street, 3011 Limassol, Cyprus

Product name and form

Moxarin 250 mg hard capsules.

Moxarin 500 mg hard capsules.

Pharmaceutical Form

Capsule, hard.

  • 250 mg capsules: grey coloured body /pink coloured cap, size number “2”.
  • 500 mg capsules: white coloured body/maroon coloured cap, size number “0”.

Qualitative and quantitative composition

Moxarin hard capsules contain the equivalent of either 250 mg or 500 mg amoxicillin as amoxicillin trihydrate E.P.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Amoxicillin

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.

List of Excipients

Moxarin hard capsules 250 mg coloured grey (body)/pink (cap) contain magnesium stearate.

The capsule body contains:

Gelatine
Black iron oxide (E172)
Titanium dioxide (E171)

The capsule cap contains:

Erythrosine (FD & C Red No.3) (E127)
Red iron oxide (E172)
Black iron oxide (E172)
Titanium dioxide (E171)
Gelatine

Moxarin hard capsules 500 mg coloured grey (body)/pink (cap), contain magnesium stearate.

The capsule body contains:

Gelatine
Black iron oxide (E172)
Titanium dioxide (E171)

The capsule cap contains:

Erythrosine (FD & C Red No.3) (E127)
Red iron oxide (E172)
Black iron oxide (E172)
Titanium dioxide (E171)
Gelatine

Pack sizes and marketing

Moxarin capsules 250 mg and 500 mg are presented in polyvinylchloride film-aluminium foil blisters of 10 capsules each. Blisters, with a leaflet, are presented in card cartons. Packs containing 20 or 100 capsules and boxes of 500 and 1000 capsules are available.

Not all pack sizes may be marketed.

Marketing authorization holder

Codal-Synto Ltd, 21 Constantinoupoleos Street, 3011 Limassol, Cyprus

Marketing authorization dates and numbers

Moxarin 250 mg capsules: 22196
Moxarin 500 mg capsules: 22197

Moxarin 250 mg capsules: 26/05/2015 / 08/04/2021
Moxarin 500 mg capsules: 26/05/2015 / 08/04/2021

Drugs

Drug Countries
MOXARIN Cyprus, Hong Kong

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.